“We give companies patent monopolies that allow them to sell drugs at mark-ups of several thousand percent above their production costs. How can we be surprised when they lie or conceal information to push their drugs as widely as possible?”
The price-gouging bill was passed by the Democrat-led General Assembly with near unanimous support this year and only governs off-patent and generic drugs, not branded medications protected by patent laws.
BALTIMORE — A trade group for generic drugmakers brought a federal complaint Thursday to block Maryland’s attempt of a crackdown on pharmaceutical price gouging. Set to take effect in October without the signature of Republican Gov. Larry